ACM
DGX icon

Aster Capital Management’s Quest Diagnostics DGX Stock Holding History

Aster Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23
Closed -$4.13K – 1054
2025
Q2 		$4.13K Sell
23
-9,106
-100% -$1.58M ﹤0.01% 887
2025
Q1 		$1.58M Buy
9,129
+9,123
+152,050% +$1.5M 0.29% 88
2024
Q4 		$905 Sell
6
-564
-99% -$87.7K ﹤0.01% 1016
2024
Q3 		$88.5K Buy
+570
New +$85.1K 0.02% 392

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aster Capital Management's DGX Position: Q3 2025 in Review

Aster Capital Management sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 23 shares — an estimated $4.13K sold.

Aster Capital Management first reported a position in DGX in Q3 2024 and held it in 4 quarters. The position peaked at $1.58M in Q1 2025. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Aster Capital Management reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Aster Capital Management sold 23 Quest Diagnostics shares in Q3 2025, an estimated $4.13K.
  • Aster Capital Management first reported a position in Quest Diagnostics in Q3 2024 and held it in 4 quarters.
  • Aster Capital Management's Quest Diagnostics position peaked at $1.58M in Q1 2025.
  • 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Aster Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.